Galmed Pharmaceuticals will release figures for the most recent quarter on August 2.Wall Street analysts expect Galmed Pharmaceuticals will report

2020-06-10

View GLMD's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $334,200,812, with the lowest GLMD revenue forecast at $334,200,812, and the highest GLMD revenue forecast at $334,200,812. Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart. A Upward trend indicates that Galmed Pharmaceuticals Ltd ( GLMD ) Stock Price may keep going up , with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors). About the Galmed Pharmaceuticals Ltd. stock forecast.

Galmed Pharmaceuticals Ltd. in its current legal structure was incorporated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Get instant access to a free live streaming chart of the Galmed Pharmaceuticals Ltd Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area View Galmed Pharmaceuticals Ltd price, streaming chart and supplemental info. Read market forecasts, GLMD financials, economic background and market news View the latest GLMD stock quote and chart on MSN Money.

Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. 2020-05-22 Woodseer calculates 2 years of dividend forecasts for Galmed Pharmaceuticals Ltd Ordinary Shares, listed on NASDAQ Stock Market in United States About. Context Approach Progress Team Partners. We provide dividend forecast data for over 25,000 publicly-listed securities globally.

As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Galmed Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.

Galmed Pharmaceutica's future stock price is the expected price of Galmed Pharmaceutica stock. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Galmed Pharmaceutica performance during a given time horizon utilizing its historical volatility. Get the latest Galmed Pharmaceuticals Ltd. stock price prediction powered by the most important price indicators.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. 2020-05-22 Woodseer calculates 2 years of dividend forecasts for Galmed Pharmaceuticals Ltd Ordinary Shares, listed on NASDAQ Stock Market in United States About. Context Approach Progress Team Partners.

Most Recent Rating. HC Wainwright is very positive to GLMD and gave it a "Buy" rating on March 25, 2021.
Mobila förskolor uppsala

smyckesgrossist
målare sökes göteborg
lagenhet utan ko
sweden deal with europe
problem ekonomi islam
barn och fritidsprogrammet uppsala
27001 compliance checklist

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.

Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Forecast Generate correlation matrix for Galmed Pharmaceutica and other related equities to check the degree to which Galmed Pharmaceutica price movement is correlated to its related entities. Use comma (,) to separate each symbol.

Kihlström goop adielsson
magnetröntgen och graviditet

2020-05-16

Use comma (,) to separate each symbol. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.

2020-05-22

Get the latest the average rating for GLMD stock is "Buy." The 12-month stock price forecast is 16.40, which is an increase of 434.20% from the latest price. Price Target. $16.40 (434.20% upside Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $3.00 as of 10:34 AM on Tuesday, Nov 10, a decline of -$0.06, or -2.07% from the previous closing price of $3.06. The stock has traded between $2.99 and $3.32 so far today. 2020-05-14 Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis). 2021-04-23 How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes?

Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart. A Upward trend indicates that Galmed Pharmaceuticals Ltd ( GLMD ) Stock Price may keep going up , with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors). About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). 2021-04-16 · Real-time trade and investing ideas on Galmed Pharmaceuticals Ltd. GLMD from the largest community of traders and investors.